S&P 500   0.62 (-3.91%)
DOW   0.62 (-3.91%)
QQQ   260.37 (+0.71%)
AAPL   388.23 (+1.65%)
MSFT   208.35 (+0.62%)
FB   239.73 (+0.31%)
GOOGL   1,520.86 (+0.57%)
AMZN   3,084.00 (-0.64%)
NVDA   415.08 (+3.23%)
CGC   17.38 (+0.46%)
BABA   248.58 (-1.23%)
MU   49.71 (+0.51%)
GE   6.88 (+2.69%)
TSLA   1,516.80 (+1.32%)
AMD   54.72 (+2.11%)
T   29.96 (+0.64%)
ACB   11.75 (-2.73%)
F   6.36 (+4.78%)
GILD   77.19 (+0.67%)
DIS   118.66 (+2.08%)
NFLX   524.88 (-0.12%)
BAC   24.14 (-0.21%)
BA   179.96 (+2.45%)
S&P 500   0.62 (-3.91%)
DOW   0.62 (-3.91%)
QQQ   260.37 (+0.71%)
AAPL   388.23 (+1.65%)
MSFT   208.35 (+0.62%)
FB   239.73 (+0.31%)
GOOGL   1,520.86 (+0.57%)
AMZN   3,084.00 (-0.64%)
NVDA   415.08 (+3.23%)
CGC   17.38 (+0.46%)
BABA   248.58 (-1.23%)
MU   49.71 (+0.51%)
GE   6.88 (+2.69%)
TSLA   1,516.80 (+1.32%)
AMD   54.72 (+2.11%)
T   29.96 (+0.64%)
ACB   11.75 (-2.73%)
F   6.36 (+4.78%)
GILD   77.19 (+0.67%)
DIS   118.66 (+2.08%)
NFLX   524.88 (-0.12%)
BAC   24.14 (-0.21%)
BA   179.96 (+2.45%)
S&P 500   0.62 (-3.91%)
DOW   0.62 (-3.91%)
QQQ   260.37 (+0.71%)
AAPL   388.23 (+1.65%)
MSFT   208.35 (+0.62%)
FB   239.73 (+0.31%)
GOOGL   1,520.86 (+0.57%)
AMZN   3,084.00 (-0.64%)
NVDA   415.08 (+3.23%)
CGC   17.38 (+0.46%)
BABA   248.58 (-1.23%)
MU   49.71 (+0.51%)
GE   6.88 (+2.69%)
TSLA   1,516.80 (+1.32%)
AMD   54.72 (+2.11%)
T   29.96 (+0.64%)
ACB   11.75 (-2.73%)
F   6.36 (+4.78%)
GILD   77.19 (+0.67%)
DIS   118.66 (+2.08%)
NFLX   524.88 (-0.12%)
BAC   24.14 (-0.21%)
BA   179.96 (+2.45%)
S&P 500   0.62 (-3.91%)
DOW   0.62 (-3.91%)
QQQ   260.37 (+0.71%)
AAPL   388.23 (+1.65%)
MSFT   208.35 (+0.62%)
FB   239.73 (+0.31%)
GOOGL   1,520.86 (+0.57%)
AMZN   3,084.00 (-0.64%)
NVDA   415.08 (+3.23%)
CGC   17.38 (+0.46%)
BABA   248.58 (-1.23%)
MU   49.71 (+0.51%)
GE   6.88 (+2.69%)
TSLA   1,516.80 (+1.32%)
AMD   54.72 (+2.11%)
T   29.96 (+0.64%)
ACB   11.75 (-2.73%)
F   6.36 (+4.78%)
GILD   77.19 (+0.67%)
DIS   118.66 (+2.08%)
NFLX   524.88 (-0.12%)
BAC   24.14 (-0.21%)
BA   179.96 (+2.45%)
Log in

NASDAQ:EDITEditas Medicine SEC Filings & 10K Form

$31.62
+0.14 (+0.44 %)
(As of 07/14/2020 04:00 PM ET)
Add
Compare
Today's Range
$30.30
Now: $31.62
$32.06
50-Day Range
$25.01
MA: $29.59
$34.63
52-Week Range
$14.01
Now: $31.62
$36.78
Volume1.03 million shs
Average Volume1.00 million shs
Market Capitalization$1.75 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.04

SEC Filings

Editas Medicine (NASDAQ:EDIT) SEC Filings

DateFilerForm TypeView
06/25/2020
8:16 AM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2020
8:14 AM
Editas Medicine (Filer)
Form 424B5
05/15/2020
3:19 PM
Editas Medicine (Filer)
Form 424B5
05/08/2020
3:17 PM
Albright Charles (Reporting)
Editas Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2020
7:32 AM
Editas Medicine (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2020
6:35 AM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2020
8:15 AM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2020
3:40 PM
Editas Medicine (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/26/2020
3:26 PM
Editas Medicine (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/12/2020
4:11 PM
Editas Medicine (Subject)
Nikko Asset Management Americas, Inc. (Filed by)
Form SC 13G/A
02/12/2020
7:08 AM
Editas Medicine (Subject)
Form SC 13G/A
02/12/2020
5:13 AM
Editas Medicine (Subject)
Sumitomo Mitsui Trust Holdings, Inc. (Filed by)
Form SC 13G/A
01/10/2020
3:05 PM
Editas Medicine (Issuer)
ROBERTSON MICHELLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2019
2:07 PM
Editas Medicine (Filer)
Form CT ORDER
11/12/2019
6:06 AM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2019
3:16 PM
Abrams Judith R (Reporting)
Editas Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/24/2019
11:03 AM
Editas Medicine (Filer)
Form CT ORDER
10/10/2019
5:08 AM
Editas Medicine (Subject)
Sumitomo Mitsui Trust Holdings, Inc. (Filed by)
Form SC 13G
10/09/2019
2:41 PM
Editas Medicine (Subject)
Nikko Asset Management Americas, Inc. (Filed by)
Form SC 13G
09/30/2019
3:11 PM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2019
3:06 PM
Collins Cynthia (Reporting)
Editas Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2019
3:03 PM
Collins Cynthia (Reporting)
Editas Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2019
3:16 PM
Collins Cynthia (Reporting)
Editas Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2019
3:13 PM
Editas Medicine (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2019
3:32 PM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2019
3:31 PM
Editas Medicine (Issuer)
Hirsch Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:30 PM
Editas Medicine (Issuer)
Hopfield Jessica (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:29 PM
Editas Medicine (Issuer)
MULLEN JAMES C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:27 PM
Editas Medicine (Issuer)
Vaishnaw Akshay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:26 PM
Collins Cynthia (Reporting)
Editas Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:03 PM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2019
3:03 PM
Editas Medicine (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2019
3:10 PM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2019
3:11 PM
Editas Medicine (Filer)
Form DEFA14A
04/26/2019
3:06 PM
Editas Medicine (Filer)
Form DEF 14A
03/20/2019
3:02 PM
Editas Medicine (Issuer)
Myer Vickesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2019
3:03 PM
Editas Medicine (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/08/2019
3:02 PM
Editas Medicine (Issuer)
Ek Eric (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/07/2019
3:02 PM
Editas Medicine (Issuer)
Hopfield Jessica (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
10:32 AM
Editas Medicine (Subject)
Form SC 13G
02/12/2019
12:26 PM
Editas Medicine (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
02/11/2019
10:17 AM
Editas Medicine (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/11/2019
10:15 AM
Editas Medicine (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/08/2019
6:37 PM
Albright Charles (Reporting)
Editas Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
6:35 PM
Editas Medicine (Issuer)
Myer Vickesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2019
3:41 PM
Editas Medicine (Issuer)
Scadden David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2019
3:38 PM
Editas Medicine (Issuer)
Scadden David (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/07/2019
3:01 PM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2019
3:41 PM
Editas Medicine (Issuer)
Hack Andrew A. F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2019
4:36 PM
Collins Cynthia (Reporting)
Editas Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2019
4:32 PM
Editas Medicine (Issuer)
Myer Vickesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2019
4:29 PM
Albright Charles (Reporting)
Editas Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2019
8:07 AM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/18/2019
7:58 PM
Editas Medicine (Issuer)
Myer Vickesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2019
3:11 PM
Bosley Katrine (Reporting)
Editas Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2019
4:36 PM
Editas Medicine (Issuer)
Hack Andrew A. F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2019
4:34 PM
Editas Medicine (Issuer)
Hack Andrew A. F. (Reporting)
Form 4/A
01/08/2019
4:32 PM
Editas Medicine (Issuer)
Hack Andrew A. F. (Reporting)
Form 4/A
12/21/2018
8:15 AM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2018
3:41 PM
Editas Medicine (Issuer)
Myer Vickesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2018
8:14 AM
Collins Cynthia (Reporting)
Editas Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2018
8:10 AM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2018
8:08 AM
Collins Cynthia (Reporting)
Editas Medicine (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/06/2018
3:02 PM
Bosley Katrine (Reporting)
Editas Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2018
3:25 PM
Editas Medicine (Issuer)
Hack Andrew A. F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2018
3:03 PM
Editas Medicine (Issuer)
Myer Vickesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2018
7:46 AM
Editas Medicine (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2018
3:12 PM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2018
4:42 PM
Bosley Katrine (Reporting)
Editas Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2018
4:05 PM
Editas Medicine (Issuer)
Hack Andrew A. F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2018
3:01 PM
Editas Medicine (Filer)
Form 10-Q/A
10/19/2018
3:01 PM
Editas Medicine (Issuer)
Myer Vickesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2018
2:52 PM
Editas Medicine (Filer)
Form CT ORDER
10/18/2018
2:40 PM
Editas Medicine (Filer)
Form CT ORDER
10/18/2018
2:33 PM
Editas Medicine (Filer)
Form CT ORDER
10/03/2018
3:03 PM
Bosley Katrine (Reporting)
Editas Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2018
3:02 PM
Editas Medicine (Issuer)
Hack Andrew A. F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2018
3:03 PM
Editas Medicine (Issuer)
Myer Vickesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2018
3:02 PM
Bosley Katrine (Reporting)
Editas Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2018
3:04 PM
Editas Medicine (Issuer)
Hack Andrew A. F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2018
3:16 PM
Bosley Katrine (Reporting)
Editas Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2018
3:09 PM
Editas Medicine (Issuer)
Myer Vickesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2018
10:16 AM
Editas Medicine (Subject)
FMR LLC (Filed by)
Form SC 13G/A
08/07/2018
3:02 PM
Editas Medicine (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2018
3:10 PM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/03/2018
3:01 PM
Bosley Katrine (Reporting)
Editas Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2018
3:07 PM
Editas Medicine (Issuer)
Myer Vickesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2018
3:00 PM
Bosley Katrine (Reporting)
Editas Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2018
3:57 PM
Editas Medicine (Issuer)
Myer Vickesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2018
3:54 PM
Editas Medicine (Issuer)
Myer Vickesh (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/19/2018
3:05 PM
Editas Medicine (Issuer)
Nikolic Boris (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2018
3:04 PM
Editas Medicine (Issuer)
Vaishnaw Akshay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2018
3:04 PM
Editas Medicine (Issuer)
Hirsch Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2018
3:02 PM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2018
3:16 PM
Albright Charles (Reporting)
Editas Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2018
3:18 PM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2018
3:06 PM
Bosley Katrine (Reporting)
Editas Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/25/2018
3:31 PM
Albright Charles (Reporting)
Editas Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2018
4:28 PM
Editas Medicine (Issuer)
MULLEN JAMES C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2018
3:27 PM
Editas Medicine (Issuer)
Hopfield Jessica (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 7/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.